NRIX
Price
$9.65
Change
-$0.19 (-1.93%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
752.26M
59 days until earnings call
PROK
Price
$2.25
Change
-$0.33 (-12.74%)
Updated
Aug 11, 04:59 PM (EDT)
Capitalization
345.56M
99 days until earnings call
Interact to see
Advertisement

NRIX vs PROK

Header iconNRIX vs PROK Comparison
Open Charts NRIX vs PROKBanner chart's image
Nurix Therapeutics
Price$9.65
Change-$0.19 (-1.93%)
Volume$13.54K
Capitalization752.26M
ProKidney
Price$2.25
Change-$0.33 (-12.74%)
Volume$47.31K
Capitalization345.56M
NRIX vs PROK Comparison Chart in %
Loading...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRIX vs. PROK commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRIX is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (NRIX: $9.84 vs. PROK: $2.59)
Brand notoriety: NRIX and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRIX: 62% vs. PROK: 13%
Market capitalization -- NRIX: $752.26M vs. PROK: $345.56M
NRIX [@Biotechnology] is valued at $752.26M. PROK’s [@Biotechnology] market capitalization is $345.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRIX’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • NRIX’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRIX’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 5 bullish TA indicator(s).

  • NRIX’s TA Score: 3 bullish, 6 bearish.
  • PROK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PROK is a better buy in the short-term than NRIX.

Price Growth

NRIX (@Biotechnology) experienced а -10.79% price change this week, while PROK (@Biotechnology) price change was -8.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +22.22%. For the same industry, the average monthly price growth was +31.78%, and the average quarterly price growth was +19.63%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+22.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($752M) has a higher market cap than PROK($346M). PROK YTD gains are higher at: 53.254 vs. NRIX (-47.771). PROK has higher annual earnings (EBITDA): -160.12M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. PROK (328M). PROK has less debt than NRIX: PROK (3.37M) vs NRIX (51.9M). NRIX has higher revenues than PROK: NRIX (88.4M) vs PROK (306K).
NRIXPROKNRIX / PROK
Capitalization752M346M217%
EBITDA-212.78M-160.12M133%
Gain YTD-47.77153.254-90%
P/E RatioN/AN/A-
Revenue88.4M306K28,889%
Total Cash486M328M148%
Total Debt51.9M3.37M1,541%
TECHNICAL ANALYSIS
Technical Analysis
NRIXPROK
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
68%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
62%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 5 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 5 days ago
65%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEYCX34.680.32
+0.93%
American Century Equity Growth C
FAAIX30.160.10
+0.33%
Fidelity Advisor Asset Manager 70% I
CHUSX30.490.04
+0.13%
Alger Global Equity A
DCFGX36.36-0.05
-0.14%
Dunham Focused Large Cap Growth C
BGLUX45.08-0.31
-0.68%
Baron Global Advantage R6

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-2.28%
KYMR - NRIX
68%
Closely correlated
-0.56%
DNLI - NRIX
59%
Loosely correlated
-1.90%
IDYA - NRIX
59%
Loosely correlated
+3.08%
CRNX - NRIX
55%
Loosely correlated
-3.69%
BEAM - NRIX
54%
Loosely correlated
-1.34%
More

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
+0.97%
CYCC - PROK
57%
Loosely correlated
-2.12%
RLYB - PROK
45%
Loosely correlated
+3.91%
LGVN - PROK
45%
Loosely correlated
-46.62%
NRIX - PROK
39%
Loosely correlated
-2.28%
APGE - PROK
38%
Loosely correlated
-1.69%
More